Related Experiment Video
Updated: Jun 19, 2026

Modeling Neuronal Death and Degeneration in Mouse Primary Cerebellar Granule Neurons
Published on: November 6, 2017
The cell death-inducing activity of the peptide containing Noxa mitochondrial-targeting domain is associated with
Young-Woo Seo1, Ha-Na Woo, Sujan Piya
1Departments of Biochemistry, Anatomy, and Medical Science and Engineering Research Center for Resistant Cells, Chosun University School of Medicine, Gwang-ju, Korea.
Abstract:
DNA damage stabilizes the p53 tumor suppressor protein that determines the cell fate by either cell cycle arrest or cell death induction. Noxa, the BH3-only Bcl-2 family protein, was shown to be a key player in p53-induced cell death through the mitochondrial dysfunction; however, the molecular mechanism by which Noxa induces the mitochondrial dysfunction to cause cell death in response to genotoxic agents is largely unknown. Here, we show that the mitochondrial-targeting domain (MTD) of Noxa is a prodeath domain. Peptide containing MTD causes massive necrosis in vitro through cytosolic calcium increase; it is released from the mitochondria by opening the mitochondrial permeability transition pore. MTD peptide-induced cell death can be inhibited by calcium chelator BAPTA-AM. Moreover, MTD peptide shows the potent tumor-killing activities in mice by joining with tumor-homing motifs.
Insights
The mitochondrial-targeting domain of Noxa protein induces cell death by increasing calcium levels. This domain shows potent tumor-killing activity in mice, offering a potential new cancer therapy.
Area of Science:
- Molecular Biology
- Cell Biology
- Biochemistry
Background:
- DNA damage activates p53, a tumor suppressor protein, influencing cell fate via arrest or death.
- Noxa, a Bcl-2 family protein, mediates p53-induced apoptosis through mitochondrial dysfunction.
- The precise mechanism of Noxa-induced mitochondrial dysfunction in response to genotoxic agents remains unclear.
Purpose of the Study:
- To elucidate the molecular mechanism by which Noxa induces mitochondrial dysfunction and cell death.
- To investigate the role of the mitochondrial-targeting domain (MTD) of Noxa in cell death.
- To evaluate the therapeutic potential of Noxa MTD peptides in cancer treatment.
Main Methods:
- In vitro studies using peptides containing Noxa's MTD.
- Measurement of cytosolic calcium levels.
- Analysis of mitochondrial permeability transition pore opening.
- In vivo studies using tumor-homing motifs conjugated to MTD peptides in mice.
Main Results:
- The MTD of Noxa functions as a prodeath domain.
- Noxa MTD peptide induces massive necrosis in vitro, associated with increased cytosolic calcium.
- MTD peptide release from mitochondria occurs via mitochondrial permeability transition pore opening.
- MTD peptide-induced cell death is preventable with the calcium chelator BAPTA-AM.
- MTD peptide demonstrates significant tumor-killing efficacy in mice when linked to tumor-homing motifs.
Conclusions:
- The Noxa MTD is a critical mediator of genotoxic-induced cell death.
- Noxa MTD triggers necrosis through calcium dysregulation and mitochondrial pore opening.
- Noxa MTD peptides represent a promising strategy for developing novel cancer therapeutics.
Related Concept Videos
Necrosis
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become anucleated and die, but their...
The Intrinsic Apoptotic Pathway
Autophagic Cell Death
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and pro-apoptotic...
Cellular Injury IV: Necrosis
The Extrinsic Apoptotic Pathway
Apoptosis
